HIV Vaccines (X8) 2016

HIV Vaccines (X8) 2016 is organized by Keystone Symposia on Molecular and Cellular Biology and would be held during Mar 20 - 24, 2016 at Resort at Squaw Creek, Olympic Valley, California, United States of America. The targeted audience for this medical meeting basically for Physicians.

Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including:
1) Initial virus transmission events for vaccine intervention,
2) Non-neutralizing antibody correlates of sterilizing immunity;
3) Epitopes, structures and ontogeny of broadly neutralizing antibodies;
4) Novel vaccine concepts for broadly neutralizing antibody induction; and
5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine. Session Topics:
• Acute HIV Infection and Initial Transmission Events (Joint)
•Immunologic Correlates of Sterilizing Immunity
•Epitopes, Structures and Ontogeny of Broadly Neutralizing Antibodies
• Vaccine Concepts I & II
•Pathways Leading to Long-Term Protective Immunity Against HIV-1
•Immunotherapy (Joint)
•Bridging Innate and Acquired Immunity